Medical Devices

Next Generation Diabetes Therapy and Drug Delivery Market by Product Type (Inhalable Insulin, Oral Insulin, Insulin Patches, CGM Systems, and Artificial Pancreas), Demographic [Adult Population (>14 years) & Child Population (<14 years)], Indication (Type 1 Diabetes & Type 2 Diabetes), and End Users (Diagnostics/Clinics, ICUs, and Home Healthcare) - Global Opportunity Analysis and Industry Forecast, 2014-2023

  • ALL1150239
  • 140 Pages
  • April 2017
  • Medical Devices

Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level. Oral & inhalable insulin painlessly manage the blood glucose level, and is expected to replace the injectable insulins. The use of advanced diabetic systems, such as insulin patches, CGM systems, and artificial pancreas is expected to maintain adherence to medication in diabetic patients and improve the quality of life of diabetic patients. The global next generation diabetes therapy and drug delivery market was valued at $617 million in 2015, and is estimated to reach $9,673 million by 2023, registering a CAGR of 41.1% from 2016 to 2023.

The global next generation diabetes therapy and drug delivery market is segmented based on product type, demographic, indication, end user, and geography. Based on product type, it is classified into inhalable insulin, oral insulin, insulin patches, continuous glucose monitoring (CGM) systems, and artificial pancreas. Based on demographics, it is bifurcated into adult population (>14 years) and child population (≤14 years). Based on indication, it is divided into type 1 diabetes and type 2 diabetes. Based on end users, it is categorized into diagnostic/clinic, ICU, and home healthcare. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The market growth is attributed to the rise in the number of diabetic patients globally and the increase in disposable income among these patients. The benefits of using these advanced devices over conventional products, such as painless mode of insulin delivery and improvement in adherence to medication, and rise in the healthcare expenditure are expected to increase the demand for these products, thus fueling the market growth. However, lack of awareness, cost restrains in the developing regions, and less variability in products are expected to hamper the growth.


  • This report offers a detailed quantitative analysis of the current market trends from 2014 to 2023 to identify the prevailing opportunities.
  • The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry.
  • The global market is comprehensively analyzed with respect to product type, demographic, indication, end user, and geography.
  • In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning.
  • The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.


  • Johnson & Johnson
  • Abbott Laboratories
  • Medtronic, Inc.
  • Sanofi
  • Novo Nordisk
  • MannKind Corporation
  • Enteris BioPharma
  • Dexcom, Inc.
  • Senseonics Holding, Inc.
  • Medtech


By Product Type

  • Inhalable Insulin
  • Oral Insulin
  • Insulin Patches
  • CGM Systems
  • Artificial Pancreas

By Demographic

  • Adult Population (>14years)
  • Child Population (≤14years)
  • By Indication
  • Type 1 Diabetes
  • Type 2 Diabetes

By End User

  • Diagnostics/Clinics
  • ICUs
  • Home Healthcare

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
    • Brazil
    • Republic of South Africa
    • Saudi Arabia
    • Rest of LAMEA

The other players of the catheters market include (companies not profiled in the report):

  • Synertech
  • Zosano Pharma Corp.
  • Relmada Therapeutics, Inc.
  • Eli Lilly and Company
  • Transdermal Specialties Inc.
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+91 20 66346066
--- or ---



World Anesthesia Monitoring Devices Market - Opportunities and Forecasts, 2014 - 2020

Anesthesia can be monitored depending on the types of cases performed for the purpose of continuous assessment of the patients by measuring parameters such as patients oxygenation, circulation, ventilation, and temperature. It is logical that other clinical observations be supplemented to different monitoring devices.

April 2018| $5370 | Pre Book Price:$4699

World Anti-Snoring Devices and Snoring Surgery Market - Opportunities and Forecasts, 2014 - 2020

The anti-snoring devices and snoring surgery market has gained traction in the recent years due to growing consciousness about the ill effects of snoring and sleep apnea, and these treatments ...

April 2018| $5370 | Pre Book Price:$4699

World Sports Medicine Market - Opportunities and Forecasts, 2014 - 2020

The sports medicine market consists of products used by athletes or sportspersons to prevent injuries and protect themselves including devices that boost performance. The product offerings play a crucial role in the rehabilitation, recovery, endurance, and monitoring of athletes in sports.

April 2018| $5370 | Pre Book Price:$4699

World 3D Printing Medical Devices Market - Opportunities and Forecasts, 2014 - 2020

Large patient population, expansion of distribution networks by the key market players, awareness about benefits of 3D printing technology and its adoption across the emerging countries in Asia-Pacific are the ...

April 2018| $5370 | Pre Book Price:$4699

World Veterinary Imaging Market - Opportunities and Forecasts, 2014 - 2020

Veterinary diagnostic imaging consists of a non-invasive method of obtaining images of the animal body for the purpose of medical diagnostics. The animals considered for imaging are small companion animals, ...

April 2018| $5370 | Pre Book Price:$4699

BRIC Diabetes Care Devices Market - Opportunities and Forecasts, 2014 - 2020

Diabetes care devices helps in the management of blood glucose levels caused in patients due to inadequate insulin production or insulin resistance. The Diabetes Care Devices Market in Brazil, Russia, ...

April 2018| $5370 | Pre Book Price:$4699

2018 © Copyright Big Market Research

View Pricing >>